Eton Pharmaceuticals, Inc. (ETON)
63.35
-1.08
(-1.68%)
USD |
NASDAQ |
Aug 25, 13:38
Eton Pharmaceuticals EPS Diluted (Quarterly) : 0.3531 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.3531 |
| March 31, 2026 | 0.0493 |
| December 31, 2025 | 0.0475 |
| September 30, 2025 | -0.0716 |
| June 30, 2025 | -0.0961 |
| March 31, 2025 | -0.0585 |
| December 31, 2024 | -0.0229 |
| September 30, 2024 | 0.0236 |
| June 30, 2024 | -0.118 |
| March 31, 2024 | -0.0315 |
| December 31, 2023 | -0.0876 |
| September 30, 2023 | -0.0225 |
| June 30, 2023 | 0.1755 |
| March 31, 2023 | -0.1042 |
| December 31, 2022 | 0.036 |
| September 30, 2022 | -0.12 |
| June 30, 2022 | -0.062 |
| March 31, 2022 | -0.2107 |
| December 31, 2021 | 0.04 |
| Date | Value |
|---|---|
| September 30, 2021 | -0.2411 |
| June 30, 2021 | -0.08 |
| March 31, 2021 | 0.1927 |
| December 31, 2020 | -0.3229 |
| September 30, 2020 | -0.309 |
| June 30, 2020 | -0.2252 |
| March 31, 2020 | -0.4988 |
| December 31, 2019 | -0.1504 |
| September 30, 2019 | -0.2777 |
| June 30, 2019 | -0.1832 |
| March 31, 2019 | -0.4234 |
| December 31, 2018 | -2.239 |
| September 30, 2018 | -0.2067 |
| June 30, 2018 | -0.2179 |
| March 31, 2018 | -0.2133 |
| December 31, 2017 | -0.163 |
| September 30, 2017 | -0.1984 |
| June 30, 2017 | -0.1303 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nektar Therapeutics | -1.229 |
| Pfizer Inc. | -0.0435 |
| Elite Pharmaceuticals, Inc. | 0.0052 |
| Daré Bioscience, Inc. | -0.2003 |
| Liquidia Corp. | 0.7369 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 11.58M |
| Revenue (Quarterly) | 37.59M |
| Total Expenses (Quarterly) | 26.01M |
| Enterprise Value | 1.825B |
| Gross Profit Margin (Quarterly) | 67.61% |
| Profit Margin (Quarterly) | 30.80% |
| Earnings Yield | 0.60% |
| Operating Earnings Yield | 0.85% |
| Normalized Earnings Yield | 0.6050 |